Getting to More Effective Weight Management in Antipsychotic-Treated Youth: A Survey of Barriers and Preferences

Childhood Obesity
Ginger NicolEric Lenze

Abstract

Mentally ill youth are at risk for developing obesity, especially when they require antipsychotic treatment; moreover, they may face unique challenges in adhering to behavioral weight loss interventions. The aims of this project were to characterize the challenges families of youth with psychiatric disorders face when engaging in weight loss treatment and to gather information on attitudes and preferences for weight management interventions in this population. We devised a telephone survey to evaluate caregiver-perceived barriers/challenges to and preferences for behavioral weight loss treatment in overweight or obese mentally ill youth ages 6-18 treated with an antipsychotic agent in an outpatient setting. A total of 26 parents or primary caregivers completed the survey. The most commonly cited barriers to participation in physical activity (PA) and maintaining a healthy diet were child's dislike of PA and child's preference for energy-dense foods, respectively, which were impacted by psychiatric symptoms. Preferences for weight loss treatment included individualized, prescribed meal plans and shopping lists, and exercise support/demonstration, with a preference for Internet or cell phone applications to help with monitoring f...Continue Reading

References

Apr 4, 2006·Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing·Judith McDevittJoellen Wilbur
May 17, 2006·Clinical Pediatrics·Sarah E Barlow, Chris L Ohlemeyer
Mar 22, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dan W HauptJohn W Newcomer
Jul 17, 2007·Journal of Child and Adolescent Psychopharmacology·Scott C FlandersGabrielle A Carlson
Oct 6, 2007·Archives of Disease in Childhood·L StewartJ J Reilly
Oct 28, 2008·The International Journal of Eating Disorders·Carlos M GriloRobin M Masheb
Oct 29, 2009·JAMA : the Journal of the American Medical Association·Christoph U CorrellAnil K Malhotra
Dec 1, 2009·Clinical Psychology & Psychotherapy·C BraetM Van Winckel
Apr 7, 2010·Archives of Pediatrics & Adolescent Medicine·Elaine H MorratoJohn W Newcomer
Oct 23, 2010·Obesity·Kerri N BoutelleScott J Crow
May 6, 2011·Diabetes Care·Ebe D'Adamo, Sonia Caprio
Feb 3, 2012·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Valerie H TaylorArya M Sharma
Mar 28, 2012·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S A RoseJ Conigliaro
Aug 8, 2012·Archives of General Psychiatry·Mark OlfsonChristoph U Correll
Jan 19, 2013·Journal of Public Health Management and Practice : JPHMP·H Mollie Greves GrowBrian E Saelens
Mar 23, 2013·The New England Journal of Medicine·Gail L DaumitLawrence J Appel
Apr 17, 2013·Journal of Geriatric Psychiatry and Neurology·Roseanne D DobkinMatthew Menza
Aug 24, 2013·JAMA Psychiatry·William V BoboWayne A Ray
May 6, 2014·JAMA : the Journal of the American Medical Association·Dana DabeleaUNKNOWN SEARCH for Diabetes in Youth Study
Sep 16, 2014·The American Journal of Psychiatry·Carla A GreenVictor J Stevens

❮ Previous
Next ❯

Software Mentioned

Epi Info
SPSS

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.